Literature DB >> 11871407

Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.

N Yuki1.   

Abstract

Guillain-Barré syndrome (GBS), characterised by limb weakness and areflexia, is the prototype of postinfectious autoimmune diseases, and Campylobacter jejuni is the most frequent antecedent pathogen. GBS subsequent to C jejuni enteritis is associated with a severe, pure motor axonal variant and IgG antibodies against GM1, GM1b, GD1a, or GalNAc-GDla, gangliosides expressed in human peripheral nerves. Lipopolysaccharides of C jejuni isolated from GBS patients have ganglioside-like epitopes. Cytomegalovirus is the most common viral antecedent infection. Patients with demyelinating GBS who have had a recent CMV infection have severe sensory deficits and anti-GM2 IgM antibody. CMV-infected fibroblasts express the GM2 epitope. Fisher syndrome (FS), characterised by ophthalmoplegia, ataxia, and areflexia, is a GBS variant associated with anti-GQ1b IgG antibody. GQ1b is enriched in the cranial nerves that innervate the extraocular muscles. Some patients develop FS after C jejuni infection, and the lipopolysaccharide present bears the GQ1b epitope. Molecular mimicry is a possible cause of GBS and FS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11871407     DOI: 10.1016/S1473-3099(01)00019-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  71 in total

1.  Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.

Authors:  Christiane Caudie; Arnaud Quittard Pinon; Didier Taravel; Valérie Sivadon-Tardy; David Orlikowski; Flore Rozenberg; Tarek Sharshar; Jean Claude Raphaël; Jean Louis Gaillard
Journal:  J Neurol       Date:  2011-04-24       Impact factor: 4.849

Review 2.  [Plasma exchange as a therapeutic option in neurological disorders].

Authors:  H C Lehmann; H P Hartung; G R Hetzel; B C Kieseier
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

Review 3.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

4.  Temporal coincidence between AMAN type of GBS and myasthenia gravis.

Authors:  Jörg Kraus; Inga Teismann; Christoph Kellinghaus; Thomas Duning; E Bernd Ringelstein; Darius G Nabavi; Wolf-Rüdiger Schäbitz
Journal:  J Neurol       Date:  2007-02-17       Impact factor: 4.849

5.  Anti-ganglioside antibody-mediated activation of RhoA induces inhibition of neurite outgrowth.

Authors:  Gang Zhang; Helmar C Lehmann; Sowmia Manoharan; Mohammedali Hashmi; Sangwoo Shim; Guo-Li Ming; Ronald L Schnaar; Pablo H Lopez; Nataliia Bogdanova; Kazim A Sheikh
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

6.  Bickerstaff's brainstem encephalitis related to Campylobacter jejuni gastroenteritis.

Authors:  A M Hussain; N J Flint; S A Livsey; R Wong; P Spiers; S S Bukhari
Journal:  J Clin Pathol       Date:  2007-05-18       Impact factor: 3.411

7.  Anti-ganglioside antibodies alter presynaptic release and calcium influx.

Authors:  Brigitte Buchwald; Gang Zhang; Angela K Vogt-Eisele; Weiyi Zhang; Raheleh Ahangari; John W Griffin; Hanns Hatt; Klaus V Toyka; Kazim A Sheikh
Journal:  Neurobiol Dis       Date:  2007-07-14       Impact factor: 5.996

8.  Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.

Authors:  Damien Biotti; Sophie Boucher; Elodie Ong; Caroline Tilikete; Alain Vighetto
Journal:  J Neurol       Date:  2013-09-06       Impact factor: 4.849

9.  The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Authors:  Peggy C R Godschalk; Astrid P Heikema; Michel Gilbert; Tomoko Komagamine; C Wim Ang; Jobine Glerum; Denis Brochu; Jianjun Li; Nobuhiro Yuki; Bart C Jacobs; Alex van Belkum; Hubert P Endtz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 10.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.